40 likes | 44 Views
The global automated cell cultures market is estimated to garner a revenue of USD 27 billion by the end of 2033 by growing at a CAGR of ~10% over the forecast period, i.e., 2023 u2013 2033.
E N D
Global Automated Cell Cultures Market Growth to be Propelled at a CAGR of~10%owingtothegrowingHealthcareIndustry During 2023 –2033 Kenneth Research published a report titled“Automated Cell Cultures Market: GlobalDemandAnalysis&OpportunityOutlook2033”whichdeliversadetailed overview of the global automated cell cultures market in terms of market segmentation by product,application,end-user,andby region. Further,for thein-depthanalysis, thereportencompasses theindustry growth indicators,restraints,supply and demand risk,along with a detailed discussion on currentand futuremarket trends thatareassociated withthegrowthofthemarket. The global automated cell cultures market is expected to grow at ~10% CAGR over the forecast period, i.e., 2023-2033. The market is segmented by product into consumables and equipment. Out of these, the consumables segment is expected to hold the largest shareovertheforecastperiodintheglobalautomatedcellculturesmarket.Thisgrowing trendisdrivenby theincreasing demandforproducts thatcontainspecifictypes ofcells
or enzymes, which can be difficult or impossible to produce in large quantities using traditionalmethods. Formoreinformation’s@https://www.kennethresearch.com/report-details/global- automated-cell-cultures-market-/10059328 Demandforcellculturetechnologyinvaccineproductionisgrowing,increasingdemand from the food and beverage industry, and increasing the prevalence of infectious and chronicdiseasestoincreasethegrowthof theglobalautomatedcellculturesmarket. Geographically, the global automated cell cultures market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Out of them, the market in the North America region is projected to hold the largest market share by the end of 2033. The rise in demand for customized medicine, the increase in R&D efforts for cancer and other chronic diseases, rising R&D spending, and the existence of key companies in the area are the main causes of the marketexpansioninthe region. The research is global in nature and covers a detailed analysis of the market in North America(U.S.,Canada),Europe(U.K., Germany,France,Italy,Spain,Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest ofLatinAmerica),Asia-Pacific(China,India,Japan,SouthKorea,Indonesia,Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, RestoftheMiddleEastandAfrica).Inaddition,analysis comprisingmarketsize, Y-O-Y growth&opportunityanalysis,marketplayers’competitivestudy,investment opportunities, demand for future outlook, etc. have also been covered and displayed in the research report. Demand for Cell Culture Technology in Vaccine Production is Growing to DrivetheGrowth oftheMarket
According to recent statistics, the cell culture-based vaccination was given to 50% of people,50%ofwhom were youngstersbetween the ages of4 and17. Oneofthemostdangerous humanpathogens andamajorcontributortoacute respiratoryinfections istheinfluenza virus. Eachyear,seasonalinfluenzaaffects between 10% and 30% of the population in the European Union, results in between 4 and50millionsymptomaticcases,andkillsbetween15,000and70,000individuals.The three (trivalent) or four (quadrivalent) influenza virus strains are used in influenza vaccinations. However,automatingcellculturingrequiresexpensiveequipmentand labor, automation may lead to diminishing returns, and regulatory issues related to cellular therapy remain unresolved the challenges affecting the market growth are expected to operate as key restraints to the growth of the global automated cell cultures market over the forecast period. This report also provides the existing competitive scenario of some of the key players of the global automated cell cultures market which includes company profiling of Hitachi, Ltd., Thermo Fisher Scientific, Inc., Sartorius AG, Hamilton Company, F. Hoffmann-La RocheLtd.,MerckKGaA,Becton,DickinsonandCompany,CellCultureCompany,LLC., Lonza Group, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts a detailed overview of the global automatedcellcultures marketthatwillhelpindustryconsultants,equipment manufacturers,existingplayerssearchingfor expansionopportunities,newplayers searchingforpossibilities,andotherstakeholderstoaligntheirmarket-centricstrategies according totheongoing andexpectedtrends in thefuture. RequestReport Sample@https://www.kennethresearch.com/sample-request- 10059328 KennethResearch isaleadingserviceproviderfor strategicmarketresearch and consulting.Weaimtoprovideunbiased,unparalleledmarketinsightsandindustry
analysistohelpindustries,conglomerates,andexecutivestotakewisedecisionsfortheir futuremarketingstrategy,expansionandinvestment,etc.Webelieveeverybusinesscan expandtoitsnewhorizon,providedtherightguidanceatarighttimeisavailablethrough strategic minds. Our out of box thinking helps our clients to take wise decisions to avoid future uncertainties. ContactformoreInfo: AJDaniel Email:sales@kennethresearch.com U.S. Phone:+13134620609